Literature DB >> 31464874

Safety profile and impact of low-titer group O whole blood for emergency use in trauma.

James Williams1, Nicholas Merutka, David Meyer, Yu Bai, Samuel Prater, Rodolfo Cabrera, John B Holcomb, Charles E Wade, Joseph D Love, Bryan A Cotton.   

Abstract

PURPOSE: Following US military implementation of a cold-stored whole blood program, several US trauma centers have begun incorporating uncrossmatched, group O cold-stored whole blood into civilian trauma resuscitation. We set out to evaluate the safety profile, transfusion reactions events, and impact of low-titer group O whole blood (LTO-WB) at our center.
METHODS: In November 2017, we added LTO-WB to each of our helicopters and to our emergency department (ED) refrigerator, alongside that of existing red blood cells and plasma. We collected information on all patients with trauma receiving prehospital or ED transfusion of uncrossed, emergency release blood products between November 2017 and June 2018. Patients were divided into those receiving any LTO-WB and those receiving only red blood cell and or plasma (COMP). Serial hemolysis panels were obtained at 3 hours, 24 hours, and 48 hours. All data were run using STATA 12.1. Statistical significance was set at p < 0.05.
RESULTS: One hundred ninety-eight patients received LTO-WB and 152 patients received COMP. There were no differences in age, sex, or mechanism. The LTO-WB patients had higher chest Abbreviated Injury Scale scores (median, 3 vs. 2; p = 0.027), as well as worse arrival base excess (median, -7 vs. -5; p = 0.014) and lactate (5.1 vs. 3.5; p < 0.001). The LTO-WB patients received less post-ED blood products than the COMP patients (median, 0 vs. 3; p = 0.001). There was no difference in survival (LTO-WB, 73%; COMP, 74%; p = 0.805). There were only two suspected transfusion reactions, both in the COMP group (p = 0.061). There was no difference in hemolysis panel values. Controlling for age, severity of injury, and prehospital physiology, LTO-WB was associated with a 53% reduction in post-ED blood product transfusion (odds ratio, 0.47; 0.23-0.94 95% CI; p = 0.033) and two-fold increase in likelihood of survival (odds ratio, 2.19; 1.01-4.76 95% CI; p = 0.047).
CONCLUSION: Low-titer group O whole blood has similar evidence of laboratory hemolysis, similar transfusion reaction rates, and is associated with a reduction in post-ED transfusions and increase likelihood of survival. LEVEL OF EVIDENCE: Therapeutic, Level II.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31464874     DOI: 10.1097/TA.0000000000002498

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  23 in total

1.  The Evolution of Blood Product Use in Trauma Resuscitation: Change Has Come.

Authors:  Mark H Yazer
Journal:  Transfus Med Hemother       Date:  2021-11-02       Impact factor: 3.747

Review 2.  Bioinspired artificial platelets: past, present and future.

Authors:  Norman F Luc; Nathan Rohner; Aditya Girish; Ujjal Didar Singh Sekhon; Matthew D Neal; Anirban Sen Gupta
Journal:  Platelets       Date:  2021-08-30       Impact factor: 3.862

3.  The Story of Blood for Shock Resuscitation: How the Pendulum Swings.

Authors:  Samuel P Carmichael; Nicholas Lin; Meagan E Evangelista; John B Holcomb
Journal:  J Am Coll Surg       Date:  2021-08-12       Impact factor: 6.532

4.  The use of whole blood in traumatic bleeding: a systematic review.

Authors:  Mario Cruciani; Massimo Franchini; Carlo Mengoli; Giuseppe Marano; Ilaria Pati; Francesca Masiello; Eva Veropalumbo; Simonetta Pupella; Stefania Vaglio; Vanessa Agostini; Giancarlo Maria Liumbruno
Journal:  Intern Emerg Med       Date:  2020-09-15       Impact factor: 3.397

Review 5.  Whole Blood for Resuscitation of Traumatic Hemorrhagic Shock in Adults.

Authors:  Allison R Jones; Justin L Miller; Jan O Jansen; Henry E Wang
Journal:  Adv Emerg Nurs J       Date:  2021 Oct-Dec 01

6.  Conservation of Rh negative Low Titer O Whole Blood (LTOWB) and the need for a national conversation to define its use in trauma transfusion protocols.

Authors:  Marla Troughton; Pampee P Young
Journal:  Transfusion       Date:  2021-03-29       Impact factor: 3.157

Review 7.  Trauma-induced coagulopathy.

Authors:  Ernest E Moore; Hunter B Moore; Lucy Z Kornblith; Matthew D Neal; Maureane Hoffman; Nicola J Mutch; Herbert Schöchl; Beverley J Hunt; Angela Sauaia
Journal:  Nat Rev Dis Primers       Date:  2021-04-29       Impact factor: 65.038

8.  Life-Threatening Bleeding in Children: A Prospective Observational Study.

Authors:  Julie C Leonard; Cassandra D Josephson; James F Luther; Stephen R Wisniewski; Christine Allen; Fabrizio Chiusolo; Adrienne L Davis; Robert A Finkelstein; Julie C Fitzgerald; Barbara A Gaines; Susan M Goobie; Sheila J Hanson; Hilary A Hewes; Laurie H Johnson; Mark O McCollum; Jennifer A Muszynski; Alison B Nair; Robert B Rosenberg; Thomas M Rouse; Athina Sikavitsas; Marcy N Singleton; Marie E Steiner; Jeffrey S Upperman; Adam M Vogel; Hale Wills; Margaret K Winkler; Philip C Spinella
Journal:  Crit Care Med       Date:  2021-11-01       Impact factor: 9.296

Review 9.  Prehospital resuscitation.

Authors:  Alexandra M P Brito; Martin Schreiber
Journal:  Trauma Surg Acute Care Open       Date:  2021-05-10

10.  A pilot study of stored low titer group O whole blood + component therapy versus component therapy only for civilian trauma patients.

Authors:  Anaar E Siletz; Kevin J Blair; Richelle J Cooper; N Charity Nguyen; Scott J Lewis; Amy Fang; Dawn C Ward; Nicholas J Jackson; Tyler Rodriguez; Jonathan Grotts; Jonathan Hwang; Alyssa Ziman; Henry Magill Cryer
Journal:  J Trauma Acute Care Surg       Date:  2021-10-01       Impact factor: 3.697

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.